• Home
  • High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer.

High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer.

Author List
Chaudhary UB, Damon LE, Rugo HS, Linker CA, Navarro W, Small EJ
Publication
American journal of clinical oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1442057
Publication Year
2005
PubMed ID
15803005
Publication Title
Chaudhary UB, Damon LE, Rugo HS, Linker CA, Navarro W, Small EJ. High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer. Am J Clin Oncol. 2005 Apr; 28(2):130-7.